A study on angiogenesis-related matrix metalloproteinase networks in primary hepatocellular carcinoma

Journal of Experimental and Clinical Cancer Research

Volumn 22, Issue 3, 2003, Pages 461-470

  Ishii, Yuji ^a   Nakasato, Y ^a   Kobayashi, S ^a   Yamazaki, Y ^a   Aoki, T ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Hepatocellular carcinoma; Matrix metalloproteinases; Tissue remodeling

Indexed keywords

GELATINASE A; GELATINASE B; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; SCLEROPROTEIN; STROMELYSIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INFILTRATION; CANCER INVASION; CARCINOGENESIS; CELL PROLIFERATION; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PATHOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; FIBROSIS; HEPATITIS, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0141447422     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Murphy G., Docheherty A.J.P.: The matrix metalloproteinases and their inhibitors. Am. J. Respir. Cell. Mol. Biol. 7: 120-125, 1992.
2. Parsons S.L., Watson S.A., Brown P.D., Collins H.M., Steele R.J.C.: Matrixmetalloproteinases. Br. J. Surg. 84: 160-166, 1997.
3. Imai K., Yokoyama Y., Nakanishi I., et al.: Matrix metalloproteinases 7 (matrilysin) from human rectal carcinoma cells. J. Biol. Chem. 270: 6691-6697, 1995.
4. Holmbeck K., Bianco P., Caterina J., et al.: MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99: 81-92, 1999.
5. Vacca A., Moretti S., Ribatti D., et al.: Progression of mycosis fungoides is associated with changes in angiogenesis and express of the matrix metalloproteinases 2 and 9. Eur. J. Cancer 33: 1685-1692, 1997.
6. Duhamel-Clerin E., Orvarin C., Lanza F., Cazenave J.P., Klein-Soyer C.: Arterioscler. Tromb. Vacc. Biol. 17: 1931-1938, 1997.
7. Nagashima Y., Hasegawa S., Koshikawa N., et al.: Expression of matrilysin in vascular endothelial cells adjacent to matrilysin-producing tumors. Int. J. Cancer 72: 441-445, 1997.
8. Zucker S., Conner C., DiMassomo B.I., et al.: Thrombin induces the activation of progelatinase A in vascular endothelial cells. Physiologic regulation of angiogenesis. J. Biol. Chem. 270: 23730-23738, 1995.
9. Theret N., Musso O., L'Helgoualc'h A., Campion J.P., Clement B.: Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP-2 activation in injured human livers. Am. J. Pathol. 153: 945-954, 1998.
10. Takano S., Yokosuka O., Imazeki F., Tagawa M., Omata M.: Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 51 patients. Hepatology 21: 650-655, 1995.
11. Yamamoto H., Itoh Y., Adachi Y., et al.: Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma. Gastroenterology 112: 1290-1296, 1997.
12. Yamamoto H., Itoh F., Adachi Y., et al.: Messenger RNA expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human hepatocellular carcinoma. Jpn. J. Clin. Oncol. 29: 58-62, 1999.
13. Harada T., Arii S., Mise M., et al.: Membrane-type matrix metalloproteinases-1 (MT1-MMP) gene is overexpressed in highly invasive hepatocellular carcinoma. J. Hepatol. 28: 231-239, 1998.
14. Murawaki Y., Ikuta Y., Okamoto K., Koda M., Kawasaki H.: Serum matrix metalloproteinases-3 (stromelysin-1) concentration in patients with chronic liver disease. J. Pathol. 31: 474-481, 1999.
15. Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathlogic features and results of surgical treatment. Ann. Surg. 211: 277-287, 1990.
16. Buckland R.M.: Strong signals from streptoavidin-biotin. Nature 320: 557-558, 1986.
17. Shi S.R., Key M.E., Kalra K.L.: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem. 39: 741-748, 1991.
18. Yamaguchi R., Yano H., Iemura A., Ogasawara S., Haramaki M., Kojiro M.: Expression of vascular endothelial growth factor in human hepatocellular carcinoma. Hepatology 28: 68-77, 1998.
19. Takahara T., Yata Y., Watanabe A.: Matrix metalloproteinases. Kan Tan Sui (Japan) 37: 293-302, 1998.
20. Takahara T., Furui K., Yata Y., et al.: Dual expression of matrix metalloproteinases-2 and membrane-type 1-matrixmetalloproteinases in fibrotic human livers. Hepatology 26: 1521-1529, 1997.
21. Hiraoka N., Allen E., Apel I.J., Gyetko M.R., Weiss S.J.: Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysis. Cell 95: 365-377, 1998.
22. Okada Y., Gonoji Y., Naka K., et al.: Matrix metalloproteinase 9 (92-kDa gelatinase/typeIV collagenase) from HT 1080 human fibrosarcoma cells. J. Biol. Chem. 267: 21712-21719, 1992
23. Arii S., Mise M., Harada T., et al.: Overexpression of matrix metalloproteinases 9 gene in hepatocellular carcinoma with invasive potential. Hepatology 24: 316-322, 1996.
24. Kuo W.H., Chou F.P., Lu S.C., Chu S.C., Hsieh Y.S.: Significant differences in serum activities of matrix metalloproteinase-2 and -9 between HCV- and HBV-infected patients and carriers. Clinica Chimica Acta 294: 157-168, 2000.
25. Ishii Y., Nakasato Y., Yanagisawa S., Kobayashi S., Yamazaki Y., Aoki T.: Dose anti-angiogenic treatment make any contribution in cases of primary hepatocellular carcinoma? - with special reference to chemoprevention, tumor dormancy and tumor shrinkage-. Biotherapy (Japan) 16: 278-287, 2002. A selected article from JSGC